Available: [8] Hudson Biotech, A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Pentadecapeptide BPC 157 for Accelerated Repair of Acute Grade II Hamstring Strain Confirmed by MRI, clinicaltrials.gov, Clinical trial registration NCT07437547, Feb
Nevertheless, some models are more robust than others, and particular models may be of interest when testing compounds with specific mechanisms of action
The studies that do not yet exist To claim that subcutaneous GHK-Cu improves human skin, one would need, at minimum, a randomized, placebo-controlled trial in human volunteers with defined skin characteristics for example, photoaged facial skin graded at baseline
Agresta, and H
For a medically reviewed explanation, see: GLP-1 medications overview What Makes Side Effects Worse (Avoid These Mistakes) Eating heavy, oily meals, increasing dosage too quickly, not drinking enough water, and ignoring early symptoms are some of the most common mistakes that can worsen side effects
There is currently no established causal link between GLP-1 agonist use and the development of lymphoproliferative disorders in adults
